Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial

NCT ID: NCT02999594

Last Updated: 2016-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tramadol for labor analgesia: a low risk placebo controlled randomised control trial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators will administer 100mg tramadol or 2ml distilled water through intramuscular route in a blinded manner. Visual analogue score will be assessed in the beginning and every hour till four hours. patient satisfaction, safety outcomes, duration of 1st and 2nd stage of labor, proportion of women experiencing nausea, vomiting and increased sleepiness, postpartum haemorrhage,apgar score at 5 minute, need for nicu admission wiil be assessed at the end

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tramadol for Labor Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

tramadol

50mg tramadol hydrochloride will be used intramuscularly as an experimental drug for evaluating its safety and efficacy as labor analgesic

Group Type EXPERIMENTAL

Tramadol Hydrochloride

Intervention Type DRUG

50mg intramuscularly

distilled water

2ml distilled water intramuscularly will be used as a placebo.

Group Type PLACEBO_COMPARATOR

Distilled Water

Intervention Type DRUG

2ml intramuscularly

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tramadol Hydrochloride

50mg intramuscularly

Intervention Type DRUG

Distilled Water

2ml intramuscularly

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* delivering for first time(nulliparous)
* well established labor ( 3 or more contractions in a span of ten minutes
* cervical dilation of 4 cm or more
* \>= 80% effacement of cervix

Exclusion Criteria

* any medical disorder- diabetes,hypertension
* obstetric high risk factors
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maulana Azad Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

dr aastha raheja

post graduate 1st year student obstetrics and gynecology department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

dr aastha raheja

Role: PRINCIPAL_INVESTIGATOR

Maulana Azad Medical College

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

dr aastha raheja

Role: CONTACT

Phone: 8586032882

Email: [email protected]

dr krishna agarwal

Role: CONTACT

Phone: 9871214208

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mamc123

Identifier Type: -

Identifier Source: org_study_id